Mechanism of Increased Fluconazole Resistance in Candida glabrata during Prophylaxis

National Committee for Clinical Laboratory Standards

Bruck, E. (1980) · PEDIATRICS · doi:10.1542/peds.65.1.187 · Cited by 14,736 · see citing works

Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity

Hunter, P. R., & Gaston, M. A. (1988) · Journal of Clinical Microbiology · doi:10.1128/jcm.26.11.2465-2466.1988 · Cited by 3,138 · see citing works

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters

Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815 · see citing works

Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences

Sanglard, D., & Odds, F. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00181-0 · Cited by 784 · see citing works

Candidemia in Allogeneic Blood and Marrow Transplant Recipients: Evolution of Risk Factors after the Adoption of Prophylactic Fluconazole

Marr, K. A., Seidel, K., White, T. C., & Bowden, R. A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315193 · Cited by 493 · see citing works

The ATP Binding Cassette Transporter Gene <i>CgCDR1</i> from <i>Candida glabrata</i> Is Involved in the Resistance of Clinical Isolates to Azole Antifungal Agents

Sanglard, D., Ischer, F., Calabrese, D., Majcherczyk, P. A., & Bille, J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2753 · Cited by 337 · see citing works

In Vitro Activities of Ravuconazole and Voriconazole Compared with Those of Four Approved Systemic Antifungal Agents against 6,970 Clinical Isolates of Candida spp

Pfaller, M. A., Messer, S. A., Hollis, R. J., Jones, R. N., & Diekema, D. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1723-1727.2002 · Cited by 232 · see citing works

Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype

Millon, L., Manteaux, A., Reboux, G., Drobacheff, C., Monod, M., Barale, T., & Michel-Briand, Y. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.4.1115-1118.1994 · Cited by 205 · see citing works

Fluconazole Resistance Associated with Drug Efflux and Increased Transcription of a Drug Transporter Gene, PDH1 , in Candida glabrata

Miyazaki, H., Miyazaki, Y., Geber, A., Parkinson, T., Hitchcock, C. A., Falconer, D. J., Ward, D. J., Marsden, K. E., & Bennett, J. E. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1695 · Cited by 162 · see citing works

Development of Fluconazole Resistance in<i>Candida albicans</i>Causing Disseminated Infection in a Patient Undergoing Marrow Transplantation

Marr, K. A., White, T. C., van Burik, J. H., & Bowden, R. A. (1997) · Clinical Infectious Diseases · doi:10.1086/515553 · Cited by 145 · see citing works

Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata

Parkinson, T., Falconer, D. J., & Hitchcock, C. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.8.1696 · Cited by 127 · see citing works

Electrophoretic karyotypes of clinically isolated yeasts of Candida albicans and C. glabrata

Asakura, K., Iwaguchi, S., Homma, M., Sukai, T., Higashide, K., & Tanaka, K. (1991) · Journal of General Microbiology · doi:10.1099/00221287-137-11-2531 · Cited by 110 · see citing works

Inducible Azole Resistance Associated with a Heterogeneous Phenotype in Candida albicans

Marr, K. A., Lyons, C. N., Ha, K. C., Rustad, T. R., & White, T. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.52-59.2001 · Cited by 106 · see citing works

Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance

Clark, F. S., Parkinson, T., Hitchcock, C. A., & Gow, N. A. R. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.419 · Cited by 101 · see citing works

Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities

Guennec, R. L., Reynes, J., Mallié, M., Pujol, C., Janbon, F., & Bastide, J.-M. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.10.2732-2737.1995 · Cited by 77 · see citing works

Function of <i>Candida glabrata</i> ABC transporter gene, <i>PDH1</i>

Izumikawa, K., Kakeya, H., Tsai, H., Grimberg, B., & Bennett, J. E. (2003) · Yeast · doi:10.1002/yea.962 · Cited by 67 · see citing works

Electrophoretic karyotypes of Torulopsis glabrata

Kaufmann, C. S., & Merz, W. G. (1989) · Journal of Clinical Microbiology · doi:10.1128/jcm.27.10.2165-2168.1989 · Cited by 54 · see citing works

Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis [published erratum appears in J Antimicrob Chemother 1998 Sep;42(3):413]

Barchiesi, F. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.5.541 · Cited by 37 · see citing works

Clamped homogeneous electric field gel electrophoresis typing of Torulopsis glabrata isolates causing nosocomial infections

Khattak, M. N., Burnie, J., Matthews, R., & Oppenheim, B. A. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.8.2211-2215.1992 · Cited by 28 · see citing works

Electrophoretic Karyotyping and Triazole Susceptibility of Candida glabrata Clinical Isolates

Barchiesi, F., Francesco, L. F. D., Arzeni, D., Caselli, F., Gallo, D., & Scalise, G. (1999) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050255 · Cited by 18 · see citing works

Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species

Whaley, S. G., Berkow, E. L., Rybak, J. M., Nishimoto, A. T., Barker, K. S., & Rogers, P. D. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02173 · Cited by 900 · see citing works

Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyondCandida albicansandAspergillus fumigatus

Pfaller, M. A., & Diekema, D. J. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.10.4419-4431.2004 · Cited by 695 · see citing works

Efflux-Mediated Antifungal Drug Resistance

Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A., & Monk, B. C. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-08 · Cited by 608 · see citing works

Antifungal Resistance and New Strategies to Control Fungal Infections

Vandeputte, P., Ferrari, S., & Coste, A. T. (2011) · International Journal of Microbiology · doi:10.1155/2012/713687 · Cited by 507 · see citing works

Cryptococcus neoformans Overcomes Stress of Azole Drugs by Formation of Disomy in Specific Multiple Chromosomes

Sionov, E., Lee, H., Chang, Y. C., & Kwon-Chung, K. J. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000848 · Cited by 479 · see citing works

Emerging Fungal Diseases

Nucci, M., & Marr, K. A. (2005) · Clinical Infectious Diseases · doi:10.1086/432060 · Cited by 433 · see citing works

Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis

Scorzoni, L., de Paula e Silva, A. C. A., Marcos, C. M., Assato, P. A., de Melo, W. C. M. A., de Oliveira, H. C., Costa-Orlandi, C. B., Mendes-Giannini, M. J. S., & Fusco-Almeida, A. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00036 · Cited by 418 · see citing works

<i>Candida</i>Infections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal Agents

Spampinato, C., & Leonardi, D. (2013) · BioMed Research International · doi:10.1155/2013/204237 · Cited by 411 · see citing works

Candida Infections and Therapeutic Strategies: Mechanisms of Action for Traditional and Alternative Agents

Santos, G. C. D. O., Vasconcelos, C. C., Lopes, A. J. O., Cartágenes, M. D. S. D. S., Filho, A. K. D. B., do Nascimento, F. R. F., Ramos, R. M., Pires, E. R. R. B., de Andrade, M. S., Rocha, F. M. G., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01351 · Cited by 357 · see citing works

Mechanisms of Azole Resistance in Clinical Isolates of <i>Candida glabrata</i> Collected during a Hospital Survey of Antifungal Resistance

Sanguinetti, M., Posteraro, B., Fiori, B., Ranno, S., Torelli, R., & Fadda, G. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.668-679.2005 · Cited by 319 · see citing works

The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus

Fraczek, M. G., Bromley, M., Buied, A., Moore, C. B., Rajendran, R., Rautemaa‐Richardson, R., Ramage, G., Denning, D. W., & Bowyer, P. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt075 · Cited by 313 · see citing works

Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: Time for harmonization of CLSI and EUCAST broth microdilution methods

Pfaller, M. A., Andes, D., Diekema, D. J., Espinel-Ingroff, A., & Sheehan, D. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.09.002 · Cited by 314 · see citing works

Invasive candidiasis

Lass‐Flörl, C., Kanj, S. S., Govender, N. P., Thompson, G. R., Ostrosky-Zeichner, L. L., & Govrins, M. A. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00503-3 · Cited by 319 · see citing works

Regulation of multidrug resistance in pathogenic fungi

Morschhäuser, J. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.08.002 · Cited by 300 · see citing works

Gain of Function Mutations in CgPDR1 of Candida glabrata Not Only Mediate Antifungal Resistance but Also Enhance Virulence

Ferrari, S., Ischer, F., Calabrese, D., Posteraro, B., Sanguinetti, M., Fadda, G., Rohde, B., Bauser, C., Bader, O., & Sanglard, D. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000268 · Cited by 295 · see citing works

An update on antifungal targets and mechanisms of resistance in<i>Candida</i><i>albicans</i>

Akins, R. A. (2005) · Medical Mycology · doi:10.1080/13693780500138971 · Cited by 291 · see citing works

Azole Resistance in <i>Candida glabrata</i> : Coordinate Upregulation of Multidrug Transporters and Evidence for a Pdr1-Like Transcription Factor

Vermitsky, J.-P., & Edlind, T. D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3773-3781.2004 · Cited by 285 · see citing works

Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation

Sanglard, D., Coste, A., & Ferrari, S. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00578.x · Cited by 285 · see citing works

Candida glabrata: A review of its features and resistance

Rodrigues, C. F., Silva, S., & Henriques, M. (2014) · European Journal of Clinical Microbiology &amp; Infectious Diseases · doi:10.1007/s10096-013-2009-3 · Cited by 268 · see citing works

<i>Candida glabrata PDR1</i> , a Transcriptional Regulator of a Pleiotropic Drug Resistance Network, Mediates Azole Resistance in Clinical Isolates and Petite Mutants

Tsai, H.-F., Krol, A. A., Sarti, K. E., & Bennett, J. E. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1384-1392.2006 · Cited by 237 · see citing works

Pdr1 regulates multidrug resistance in <i>Candida glabrata</i> : gene disruption and genome‐wide expression studies

Vermitsky, J., Earhart, K. D., Smith, W. L., Homayouni, R., Edlind, T. D., & Rogers, P. D. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05235.x · Cited by 233 · see citing works

Systematic Phenotyping of a Large-Scale Candida glabrata Deletion Collection Reveals Novel Antifungal Tolerance Genes

Schwarzmüller, T., Ma, B., Hiller, E., Istel, F., Tscherner, M., Brunke, S., Ames, L., Firon, A., Green, B., Cabral, V., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004211 · Cited by 191 · see citing works

Multidrug Resistance in Yeast Candida

Prasad, R., & Kapoor, K. (2004) · International review of cytology · doi:10.1016/s0074-7696(04)42005-1 · Cited by 182 · see citing works

Heteroresistance to Fluconazole in <i>Cryptococcus neoformans</i> Is Intrinsic and Associated with Virulence

Sionov, E., Chang, Y. C., Garraffo, H. M., & Kwon-Chung, K. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00295-09 · Cited by 179 · see citing works

Antifungal drug resistance of oral fungi

Niimi, M., Firth, N. A., & Cannon, R. D. (2010) · Odontology · doi:10.1007/s10266-009-0118-3 · Cited by 169 · see citing works

Fungal PDR transporters: Phylogeny, topology, motifs and function

Lamping, E., Baret, P. V., Holmes, A. R., Monk, B. C., Goffeau, A., & Cannon, R. D. (2009) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.10.007 · Cited by 161 · see citing works

New pathogens, new tricks: emerging, drug‐resistant fungal pathogens and future prospects for antifungal therapeutics

Geddes‐McAlister, J., & Shapiro, R. S. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13739 · Cited by 159 · see citing works

Synthesis and antifungal activity of substituted salicylaldehyde hydrazones, hydrazides and sulfohydrazides

Backes, G. L., Neumann, D. M., & Jursic, B. S. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.07.022 · Cited by 148 · see citing works

Clinical Significance of Azole Antifungal Drug Cross-Resistance in Candida glabrata

Panackal, A. A., Gribskov, J. L., Staab, J. F., Kirby, K. A., Rinaldi, M. G., & Marr, K. A. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.5.1740-1743.2006 · Cited by 144 · see citing works

The ATP‐binding cassette transporter–encoding gene <i>CgSNQ2</i> is contributing to the <i>CgPDR1</i>‐dependent azole resistance of <i>Candida glabrata</i>

Torelli, R., Posteraro, B., Ferrari, S., La Sorda, M., Fadda, G., Sanglard, D., & Sanguinetti, M. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06143.x · Cited by 141 · see citing works

Triazole Cross-Resistance among Candida spp.: Case Report, Occurrence among Bloodstream Isolates, and Implications for Antifungal Therapy

Magill, S. S., Shields, C. E., Sears, C. L., Choti, M. A., & Merz, W. G. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.2.529-535.2006 · Cited by 137 · see citing works

Multidrug resistance in fungi: regulation of transporter-encoding gene expression

Paul, S., & Moye-Rowley, W. S. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00143 · Cited by 137 · see citing works

Variation in Susceptibility of Bloodstream Isolates ofCandida glabratato Fluconazole According to Patient Age and Geographic Location in the United States in 2001 to 2007

Pfaller, M. A., Messer, S. A., Hollis, R. J., Boyken, L. B., Tendolkar, S., Kroeger, J. S., & Diekema, D. J. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00946-09 · Cited by 128 · see citing works

Overexpression of Aldo-Keto-reductase in Azole-resistant clinical isolates of Candida glabrata determined by cDNA-AFLP

Farahyar, S., Zaini, F., Kordbacheh, P., Rezaie, S., Safara, M., Raoofian, R., & Heidari, M. (2013) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/2008-2231-21-1 · Cited by 125 · see citing works

Impact of Fluconazole Prophylaxis on Incidence and Outcome of Invasive Candidiasis in a Neonatal Intensive Care Unit

Healy, C. M., Baker, C. J., Zaccaria, E., & Campbell, J. R. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.04.016 · Cited by 122 · see citing works

The Role of IL-17 in Protection against Mucosal Candida Infections

Mengesha, B., & Conti, H. R. (2017) · Journal of Fungi · doi:10.3390/jof3040052 · Cited by 124 · see citing works

Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active β-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c

Carta, F., Maresca, A., Covarrubias, A. S., Mowbray, S. L., Jones, T. A., & Supuran, C. T. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.10.009 · Cited by 119 · see citing works

Fungicide effects on human fungal pathogens: Cross-resistance to medical drugs and beyond

Bastos, R. W., Rossato, L. L., Goldman, G. H., & Santos, D. A. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1010073 · Cited by 112 · see citing works

Treatment of Invasive Candidiasis: A Narrative Review

Ben-Ami, R. (2018) · Journal of Fungi · doi:10.3390/jof4030097 · Cited by 111 · see citing works

Contribution of CgPDR1-Regulated Genes in Enhanced Virulence of Azole-Resistant Candida glabrata

Ferrari, S., Sanguinetti, M., Torelli, R., Posteraro, B., & Sanglard, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017589 · Cited by 110 · see citing works

First Report of Candidemia Clonal Outbreak Caused by Emerging Fluconazole-Resistant Candida parapsilosis Isolates Harboring Y132F and/or Y132F+K143R in Turkey

Arastehfar, A. A., Daneshnia, F., Polat, S. H., Fang, W., Yaşar, M., Polat, F., Metin, D. Y., Rigole, P., Coenye, T., İlkit, M., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01001-20 · Cited by 110 · see citing works

Rapid Acquisition of Stable Azole Resistance by Candida glabrata Isolates Obtained before the Clinical Introduction of Fluconazole

Borst, A., Raimer, M. T., Warnock, D. W., Morrison, C. J., & Arthington, B. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.783-787.2005 · Cited by 107 · see citing works

Gene Duplication Associated with Increased Fluconazole Tolerance in Candida auris cells of Advanced Generational Age

Bhattacharya, S., Holowka, T., Orner, E. P., & Fries, B. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-41513-6 · Cited by 104 · see citing works

Study of germ tube formation by Candida albicans after photodynamic antimicrobial chemotherapy (PACT)

Munin, E., Giroldo, L. M., Alves, L. P., & Costa, M. S. (2007) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2007.04.011 · Cited by 102 · see citing works

Resistance to Antifungal Drugs

Ben‐Ami, R., & Kontoyiannis, D. P. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.003 · Cited by 101 · see citing works

Recent Trends in the Epidemiology of Fungal Infections

Seagle, E. E., Williams, S., & Chiller, T. M. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.001 · Cited by 96 · see citing works

The bZip transcription factor Cgap1p is involved in multidrug resistance and required for activation of multidrug transporter gene CgFLR1 in Candida glabrata

Chen, K.-H., Miyazaki, T., Tsai, H., & Bennett, J. E. (2006) · Gene · doi:10.1016/j.gene.2006.08.010 · Cited by 95 · see citing works

Genomewide Expression Profile Analysis of the Candida glabrata Pdr1 Regulon

Caudle, K. E., Barker, K. S., Wiederhold, N. P., Xu, L., Homayouni, R., & Rogers, P. D. (2010) · Eukaryotic Cell · doi:10.1128/ec.00073-10 · Cited by 92 · see citing works

Comparative Genomics of Hemiascomycete Yeasts: Genes Involved in DNA Replication, Repair, and Recombination

Richard, G., Kerrest, A., Lafontaine, I., & Dujon, B. (2005) · Molecular Biology and Evolution · doi:10.1093/molbev/msi083 · Cited by 91 · see citing works

Microbiota–Gut–Brain Axis: Yeast Species Isolated from Stool Samples of Children with Suspected or Diagnosed Autism Spectrum Disorders and In Vitro Susceptibility Against Nystatin and Fluconazole

Kantarcioglu, A. S., Kiraz, N., & Aydin, A. (2016) · Mycopathologia · doi:10.1007/s11046-015-9949-3 · Cited by 89 · see citing works

Heteroresistance to Fluconazole Is a Continuously Distributed Phenotype among Candida glabrata Clinical Strains Associated with <i>In Vivo</i> Persistence

Ben-Ami, R., Zimmerman, O., Finn, T., Amit, S., Novikov, A., Wertheimer, N., Lurie-Weinberger, M., & Berman, J. (2016) · mBio · doi:10.1128/mbio.00655-16 · Cited by 88 · see citing works

Azole Resistance in Candida glabrata

Whaley, S. G., & Rogers, P. D. (2016) · Current Infectious Disease Reports · doi:10.1007/s11908-016-0554-5 · Cited by 85 · see citing works

Drug resistance mechanisms and their regulation in non- albicans Candida species

Kołaczkowska, A., & Kołaczkowski, M. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv445 · Cited by 88 · see citing works

Changes in Karyotype and Azole Susceptibility of Sequential Bloodstream Isolates from Patients with <i>Candida glabrata</i> Candidemia

Shin, J. H., Chae, M. J., Song, J. W., Jung, S.-I., Cho, D., Kee, S. J., Kim, S. H., Shin, M. G., Suh, S. P., & Ryang, D. W. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00381-07 · Cited by 86 · see citing works

Evaluation of reference genes for real-time quantitative PCR studies in Candida glabrata following azole treatment

Li, Q., Skinner, J., & Bennett, J. E. (2012) · BMC Molecular Biology · doi:10.1186/1471-2199-13-22 · Cited by 85 · see citing works

Distinct Roles of Candida albicans Drug Resistance Transcription Factors TAC1 , MRR1 , and UPC2 in Virulence

Lohberger, A., Coste, A. T., & Sanglard, D. (2013) · Eukaryotic Cell · doi:10.1128/ec.00245-13 · Cited by 83 · see citing works

Microarray and Molecular Analyses of the Azole Resistance Mechanism in <i>Candida glabrata</i> Oropharyngeal Isolates

Tsai, H.-F., Sammons, L. R., Zhang, X., Suffis, S. D., Su, Q., Myers, T. G., Marr, K. A., & Bennett, J. E. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00535-10 · Cited by 80 · see citing works

Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry

Pina‐Vaz, C., Rodrigues, A. G., Costa‐de‐Oliveira, S., Ricardo, E., & Mårdh, P. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki264 · Cited by 81 · see citing works

Regulation of the CgPdr1 Transcription Factor from the Pathogen Candida glabrata

Paul, S., Schmidt, J. A., & Moye-Rowley, W. S. (2011) · Eukaryotic Cell · doi:10.1128/ec.00277-10 · Cited by 78 · see citing works

Candida glabrata Fungemia in Transplant Patients Receiving Voriconazole after Fluconazole

Alexander, B. D., Schell, W. A., Miller, J. L., Long, G. D., & Perfect, J. R. (2005) · Transplantation · doi:10.1097/01.tp.0000173771.47698.7b · Cited by 78 · see citing works

Treatment of Candida glabrata Infection in Immunosuppressed Mice by Using a Combination of Liposomal Amphotericin B with Caspofungin or Micafungin

Olson, J. A., Adler‐Moore, J., Smith, P. J., & Proffitt, R. T. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.4895-4902.2005 · Cited by 75 · see citing works

Reducing Candida Infections During Neonatal Intensive Care: Management Choices, Infection Control, and Fluconazole Prophylaxis

Long, S. S., & Stevenson, D. K. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.04.033 · Cited by 70 · see citing works

Issues in antifungal susceptibility testing

Johnson, E. M. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm427 · Cited by 68 · see citing works

Improved yeast delivery of fluconazole with a nanostructured lipid carrier system

Kelidari, H., Moazeni, M., Babaei, R., Saeedi, M., Âkbari, J., Parkoohi, P. I., Nabili, M., Gohar, A. A., Morteza‐Semnani, K., & Nokhodchi, A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.02.008 · Cited by 67 · see citing works

Gain-of-Function Mutations in <i>PDR1</i> , a Regulator of Antifungal Drug Resistance in Candida glabrata, Control Adherence to Host Cells

Vale-Silva, L., Ischer, F., Leibundgut-Landmann, S., & Sanglard, D. (2013) · Infection and Immunity · doi:10.1128/iai.00074-13 · Cited by 65 · see citing works

Synthesis and antifungal activity of substituted 2,4,6-pyrimidinetrione carbaldehyde hydrazones

Neumann, D. M., Cammarata, A., Backes, G. L., Palmer, G. E., & Jursic, B. S. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.12.010 · Cited by 65 · see citing works

Proteomic analysis of experimentally induced azole resistance in Candida glabrata

Rogers, P. D. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl221 · Cited by 64 · see citing works

Antibacterial and antifungal properties of dendronized silver and gold nanoparticles with cationic carbosilane dendrons

González, C. E. P., Pędziwiatr‐Werbicka, E., Martín‐Pérez, T., Szewczyk, E. M., Copa-Patiño, J. L., Soliveri, J., Pérez‐Serrano, J., Gómez, R., Bryszewska, M. J., Sánchez‐Nieves, J., et al. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.05.067 · Cited by 63 · see citing works

Local silencing controls the oxidative stress response and the multidrug resistance in <i> <scp>C</scp> andida glabrata </i>

Orta‐Zavalza, E., Guerrero‐Serrano, G., Gutiérrez‐Escobedo, G., Cañas‐Villamar, I., Juárez‐Cepeda, J., Castaño, I., & De Las Peñas, A. (2013) · Molecular Microbiology · doi:10.1111/mmi.12247 · Cited by 61 · see citing works

A Novel Antifungal Plasma-Activated Hydrogel

Liu, Z., Zheng, Y., Dang, J., Zhang, J., Dong, F., Wang, K., & Zhang, J. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b04700 · Cited by 62 · see citing works

Relative Contribution of the ABC Transporters Cdr1, Pdh1, and Snq2 to Azole Resistance in Candida glabrata

Whaley, S. G., Zhang, Q., Caudle, K. E., & Rogers, P. D. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01070-18 · Cited by 59 · see citing works

Skn7p is involved in oxidative stress response and virulence of Candida glabrata

Saijo, T., Miyazaki, T., Izumikawa, K., Mihara, T., Takazono, T., Kosai, K., Imamura, Y., Seki, M., Kakeya, H., Yamamoto, Y., et al. (2010) · Mycopathologia · doi:10.1007/s11046-009-9233-5 · Cited by 59 · see citing works

Pathogenesis and Antifungal Drug Resistance of the Human Fungal Pathogen Candida glabrata

Tscherner, M., Schwarzmüller, T., & Kuchler, K. (2011) · Pharmaceuticals · doi:10.3390/ph4010169 · Cited by 60 · see citing works

Multidrug transporters of Candida species in clinical azole resistance

Prasad, R., Nair, R., & Banerjee, A. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.103252 · Cited by 58 · see citing works

Azole‐resistant Candida spp. – emerging pathogens?

Tobudic, S., Kratzer, C., & Presterl, E. (2012) · Mycoses · doi:10.1111/j.1439-0507.2011.02146.x · Cited by 57 · see citing works

Candida glabrata erg1 Mutant with Increased Sensitivity to Azoles and to Low Oxygen Tension

Tsai, H., Bard, M., Izumikawa, K., Krol, A. A., Sturm, A. M., Culbertson, N. T., Pierson, C. A., & Bennett, J. E. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2483-2489.2004 · Cited by 56 · see citing works

Recent insights into the mechanisms of antifungal resistance

Barker, K. S., & Rogers, P. D. (2006) · Current Infectious Disease Reports · doi:10.1007/s11908-006-0019-3 · Cited by 54 · see citing works

Augmenting Azoles with Drug Synergy to Expand the Antifungal Toolbox

Kane, A., & Carter, D. A. (2022) · Pharmaceuticals · doi:10.3390/ph15040482 · Cited by 55 · see citing works

An Overview on Conventional and Non-Conventional Therapeutic Approaches for the Treatment of Candidiasis and Underlying Resistance Mechanisms in Clinical Strains

Salazar, S. B., Simões, R., Pedro, N. A., Pinheiro, M. J. F., Carvalho, M. F. N. N., & Mira, N. P. (2020) · Journal of Fungi · doi:10.3390/jof6010023 · Cited by 55 · see citing works

Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: Risk factors, antifungal treatment and outcome

Tumbarello, M., Sanguinetti, M., Trecarichi, E. M., La Sorda, M., Rossi, M., de Carolis, E., de Gaetano Donati, K., Fadda, G., Cauda, R., & Posteraro, B. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn381 · Cited by 53 · see citing works

Candida glabrata is unusual with respect to its resistance to cationic antifungal proteins

Helmerhorst, E. J., Venuleo, C., Beri, A., & Oppenheim, F. G. (2005) · Yeast · doi:10.1002/yea.1241 · Cited by 53 · see citing works

<i>UPC2A</i> Is Required for High-Level Azole Antifungal Resistance in Candida glabrata

Whaley, S. G., Caudle, K. E., Vermitsky, J.-P., Chadwick, S. G., Toner, G., Barker, K. S., Gygax, S. E., & Rogers, P. D. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02217-13 · Cited by 52 · see citing works

Impact of the COVID-19 Pandemic on the Clinical Profile of Candidemia and the Incidence of Fungemia Due to Fluconazole-Resistant Candida parapsilosis

Ramos, A., Pintos-Pascual, I., Guinea, J., Gutiérrez‐Villanueva, A., Abreu, E. V. G., Díaz-García, J., Asensio, Á., Iranzo, R., Sánchez‐Romero, I., Muñoz‐Algarra, M., et al. (2022) · Journal of Fungi · doi:10.3390/jof8050451 · Cited by 53 · see citing works

Fungicidal activity of human lactoferrin-derived peptides based on the antimicrobial αβ region

Kondori, N., Baltzer, L., Dolphin, G. T., & Mattsby‐Baltzer, I. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.08.020 · Cited by 52 · see citing works

The changing spectrum of Saccharomycotina yeasts causing candidemia: phylogeny mirrors antifungal susceptibility patterns for azole drugs and amphothericin B

Stavrou, A. A., Lackner, M., Lass‐Flörl, C., & Boekhout, T. (2019) · FEMS Yeast Research · doi:10.1093/femsyr/foz037 · Cited by 51 · see citing works

The photodynamic effect of methylene blue and toluidine blue on Candida albicans is dependent on medium conditions

Carvalho, G. G., Felipe, M. P., & Costa, M. S. (2009) · The Journal of Microbiology · doi:10.1007/s12275-009-0059-0 · Cited by 51 · see citing works

3D-QSAR CoMFA studies on sulfonamide inhibitors of the Rv3588c β-carbonic anhydrase from Mycobacterium tuberculosis and design of not yet synthesized new molecules

Singh, S. T., & Supuran, C. T. (2013) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2013.800059 · Cited by 50 · see citing works

Invasive Fungal Infections and Their Epidemiology: Measures in the Clinical Scenario

Bajpai, V. K., Khan, I., Shukla, S., Kumar, P., Rather, I. A., Park, Y.-H., Huh, Y. S., & Han, Y. (2019) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-018-0477-0 · Cited by 53 · see citing works

Involvement of PDK1, PKC and TOR signalling pathways in basal fluconazole tolerance in Cryptococcus neoformans

Lee, H., Lamichhane, A. K., Garraffo, H. M., Kwon-Chung, K. J., & Chang, Y. C. (2012) · Molecular Microbiology · doi:10.1111/j.1365-2958.2012.08016.x · Cited by 47 · see citing works

Molecular Evolution of Minisatellites in Hemiascomycetous Yeasts

Richard, G., & Dujon, B. (2005) · Molecular Biology and Evolution · doi:10.1093/molbev/msj022 · Cited by 45 · see citing works

Carbonic anhydrase inhibitors: Inhibition of the β-class enzyme from the pathogenic yeast Candida glabrata with sulfonamides, sulfamates and sulfamides

Vullo, D., Leewattanapasuk, W., Mühlschlegel, F. A., Mastrolorenzo, A., Capasso, C., & Supuran, C. T. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.02.092 · Cited by 46 · see citing works

Carbonic anhydrase inhibitors. Inhibition of the β-class enzyme from the pathogenic yeast Candida glabrata with anions

Innocenti, A., Leewattanapasuk, W., Mühlschlegel, F. A., Mastrolorenzo, A., & Supuran, C. T. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.06.048 · Cited by 46 · see citing works

Etiopathology, Epidemiology, Diagnosis, and Treatment of Fungal Keratitis

Bisen, A. C., Sanap, S. N., Agrawal, S., Biswas, A., Mishra, A., Verma, S. K., Singh, V., & Bhatta, R. S. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00203 · Cited by 46 · see citing works

Reliability of the Vitek 2 Yeast Susceptibility Test for Detection of In Vitro Resistance to Fluconazole and Voriconazole in Clinical Isolates of Candida albicans and Candida glabrata

Posteraro, B., Martucci, R., Sorda, M. L., Fiori, B., Sanglard, D., Carolis, E. D., Florio, A. R., Fadda, G., & Sanguinetti, M. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02070-08 · Cited by 44 · see citing works

Clotrimazole Drug Resistance in Candida glabrata Clinical Isolates Correlates with Increased Expression of the Drug: H+ Antiporters CgAqr1, CgTpo1_1, CgTpo3, and CgQdr2

Costa, C., Ribeiro, J., Miranda, I. M., Silva-Dias, A., Cavalheiro, M., Costa-de-Oliveira, S., Rodrigues, A. G., & Teixeira, M. C. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00526 · Cited by 43 · see citing works

STB5 Is a Negative Regulator of Azole Resistance in Candida glabrata

Noble, J. A., Tsai, H., Suffis, S. D., Su, Q., Myers, T. G., & Bennett, J. E. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01278-12 · Cited by 40 · see citing works

Isolation, molecular identification, and antifungal susceptibility profiles of vaginal isolates of Candida species.

Rezaei‐Matehkolaei, A., Shafiei, S., & Mahmoudabadi, A. Z. (2016) · PubMed Central · Cited by 41 · see citing works

An Introduction to the Medically Important Candida Species

Moran, G. P., Coleman, D. C., & Sullivan, D. J. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch2 · Cited by 50 · see citing works

In VivoandIn VitroAcquisition of Resistance to Voriconazole by Candida krusei

Ricardo, E., Miranda, I. M., Faria‐Ramos, I., Silva, R. M., Rodrigues, A. G., & Pina‐Vaz, C. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02603-14 · Cited by 40 · see citing works

Mechanisms of azole resistance in clinical isolates of Candida glabrata from two hospitals in China

Yao, D., Chen, J., Chen, W., Li, Z., & Hu, X. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s202058 · Cited by 38 · see citing works

Loss ofin vitroresistance inCandida glabratafollowing discontinuation of fluconazole prophylaxis in a hematopoietic stem cell transplantation patient

Westbrook, S. D., Wiederhold, N. P., Vallor, A. C., Kotara, S., Bernardo, S. M., Lee, S. A., Kirkpatrick, W. R., Toro, J. J., Freytes, C., Patterson, T. F., et al. (2010) · Medical Mycology · doi:10.3109/13693780903213504 · Cited by 3 · see citing works

Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata. Antimicrob. Agents Chemother

Miyazaki, H., Miyazaki, Y., Geber, A., Marsden, K., Bennett, J. E., Glabrata, I. C., Miyazaki, H., Miyazaki, Y., Geber, A., Parkinson, T., et al. (1998)

Fluconazole Resistance Associated with Drug Efflux and Increased Transcription of a Drug Transporter Gene, PDH1 , in Candida glabrata

Miyazaki, H., Miyazaki, Y., Geber, A., Parkinson, T., Hitchcock, C. A., Falconer, D. J., Ward, D. J., Marsden, K. E., & Bennett, J. E. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1695 · Cited by 162 · see citing works

Expression Patterns of ABC Transporter Genes in Fluconazole-Resistant Candida glabrata

Gohar, A. A., Badali, H., Shokohi, T., Nabili, M., Amirrajab, N., & Moazeni, M. (2017) · Mycopathologia · doi:10.1007/s11046-016-0074-8 · Cited by 25 · see citing works

Multiple Patterns of Resistance to Fluconazole in <i>Candida glabrata</i> Isolates from a Patient with Oropharyngeal Candidiasis Receiving Head and Neck Radiation

Redding, S. W., Kirkpatrick, W. R., Saville, S., Coco, B. J., White, W., Fothergill, A., Rinaldi, M., Eng, T., Patterson, T. F., & Lopez-Ribot, J. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.2.619-622.2003 · Cited by 85 · see citing works